ChemImage will be partnering with Next Breath to compare optical microscopy to Raman Chemical Imaging, specifically ChemImage’s Falcon II wide-field Raman chemical imaging system. The Falcon II enables
The Mobility trial is designed to study 150 patients at up to 50 centers in the US. The primary endpoint is a composite measure of major adverse events
Arca biopharma has reported data from the pivotal Phase III Best trial of Gencaro in patients with advanced chronic heart failure. The trial results demonstrated that, in a
Mr Stefano is senior vice president of GlaxoSmithKline’s payor markets division and has spent 23 years leading GlaxoSmithKline’s managed markets division. Mr Stefano has held numerous positions at
Under the terms of the all cash transaction, Strativa Pharmaceuticals will pay QOL Medical $54.5 million for the worldwide rights to Nascobal nasal spray. Nascobal nasal spray will
Under the terms of the agreement, MDRNA will receive upfront cash and double-digit profit sharing on commercial sales of calcitonin. In addition, Par will assume MDRNA’s supply and
Hyperion Therapeutics has reported positive top-line results from its Phase II study of HPN-100 for the treatment of urea cycle disorders. The Phase II study was an open-label,
Mr Williams’s career with Sanofi Pasteur began when he joined the division as a finance manager in 1978. Mr Williams held a series of increasingly senior positions, culminating
Through this new subsidiary, Genomma Lab will sell new product lines within the categories of analgesics, cold remedies, anti-fungal, anti-inflammatory, expectorants and multivitamins, among others. Genomma Lab said
Ligand Pharmaceuticals, a biotechnology company, has identified a new lead for advancement in its alliance with GlaxoSmithKline. The newly identified lead compound is from a program being evaluated
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.